Patent ID: 8236816
Filing Date: 2012-08-07
Classification: A61K,A61P

Abstract:
1. A method of treating actinic keratoses (AK) in an immunocompetent adult patient in need thereof in a six week treatment course, the method comprising: (a) topically applying a 3.75% (w/w) imiquimod composition once daily to the full face or balding scalp of the immunocompetent adult patient over a first two-week treatment period; and (b) topically applying a 3.75% (w/w) imiquimod composition once daily to the frill face or balding scalp of the immunocompetent adult patient over a second two-week treatment period; wherein the first treatment period and the second treatment period are separated by one, two-week non-treatment period during which no imiquimod is applied to the immunocompetent adult patient; wherein the method of treating actinic keratoses is completed in six weeks; and wherein in performance of the method the imiquimod is the sole active pharmaceutical ingredient required to be applied to the inn face or scalp of the immunocompetent adult patient.